Based on concerns over a growing number of reports of a blood clotting disorder known as thrombosis with thrombocytopenia syndrome (TTS) following vaccination with Johnson & Johnson/Janssen's experimental human adenovirus vectored Ad26.COV2.S vaccine, the Advisory Committee on Immunization...
Copy and paste this URL into your WordPress site to embed